throbber
SANOUIN PLASMA PRODUCTS
`
`Mt! Report Dopartrnont 0! Product MW
`
`0 Confidential
`0 For internal use
`0 Limited distribution tor:
`0 Product registration
`0 Publication
`0 Third parties
`
`Product: Cinryzo
`No.:
`080 - 152
`Page:
`1'- B
`Duo:
`15 May 2009
`
`Subloci:
`
`Stability 01 CW (,2 100 U/rri) in ookrtion
`
`Researcher.
`
`J.Bioom
`
`Summary:
`
`This moon dooorlbeelho invettigatlon lrltottiooolubmymdstnblltyot reconstituted Cinryzo
`mum-tog100Uhriotoredtorupto24homat20:2°c.itoonbooonoiudodttutcinryzo
`mwmammmummmm -5miotw.i.iwithin10min.
`Noiouoiaotivity,dogradnflonoraagrooationwndotectodaflorotorogootmntunpardureior
`uptoztivhoomontrationootuptoSOOU/ni.
`
`
`
`Page 1 of 8
`
`CSL EXHIBIT 1050
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`036-152
`
`Contents:
`
`Introduction
`1.
`2. Material and Methods
`3. Results
`4. Conclusions
`
`1.
`
`Introduction
`
`2-8
`
`Page
`
`2
`2
`2
`3
`
`For the development of a C1-inhibitor product for subcutaneous administration a more concentrated
`product is preferred. As a first experiment it was tried to dissolve the current registered Cinryze
`product in a smaller volume to obtain a product with a higher Cl-inhibitor concentration but also
`higher excipient concentrations. It was tested if the current product can be dissolved in 2.5, 2, 1.5
`or 1 ml to obtain product containing 200, 250, 333 or 500 Ulml and higher concentrations of
`excipients (Table 1). Also, the stability of this concentrated product at room temperature for up to
`24 hrs was tested.
`
`2.
`
`Material and Methods
`
`2.1. Material
`
`For the experiments vials of Cinryze batch 06002L370A were used.
`Specifications of batch 06002L370A at release were: Cl-inhibitor activity 96 Ulml; protein 14.1 g/l;
`pH 7.0; sodium 106 mmol/L; citrate 10 mmol/L; sucrose 62 mmol/L; osmolality 302 mosmollkg;
`valine 17 mmol/L; alanine 13 mmol/L; threonine 38 mmolll.
`
`2.2. Methods
`
`The solubility and stability at C1-inhibitor concentrations of 200, 250, 333 and 500 Ulml were
`tested. As a reference the product in a concentration of 100 Ulml was used. Per experiment several
`vials were used to have enough material to analyse the product at O, 1, 3, 6 and 24 hr after
`dissolution and storage at 20 1 2 °C.
`The solubility of the C1-lnhibitor protein was determined using SOP M066 (QC protocol).
`Subsequently. the vials were sampled at 5 time points, 1.6. t=0, t=1 h, t=3h, t=6h and t=24h. The
`samples were transferred to Sarstedt tubes, frozen at -30 °C and despatched for the following
`determinations: C1-inhibitor activity (SOP @0398). C1 -inhibitor antigen (SOP @2587) and HPSEC
`(SOP M916). It must be noted that the C1-inhibitor activity assay is not validated for products with
`high concentrations of C1-inhibitor and excipients (a.o. dilution effects).
`
`3.
`
`Results
`
`3.1
`
`Stability of C1-inhlbitor in solution
`
`Cinryze can be dissolved in 1 - 5 ml within 10 min. (Table 2). Only if 1 ml of w.f.i. is used, some
`material is sticking to the wall due to the small volume.
`
`Page 2 of 8
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`036-152
`
`3-8
`
`Table 1: Theoretical concentrations of excipients in Cinryze in a smaller dissolution volume than
`described in the BLA
`
`Sodium
`
`citrate
`
`L-valine
`
`L-alanlne L-threonlne
`
`Sucrose
`
`C1-lnhlbltor
`
`
`activity
`Ulml
`
`
`
`
`mmollL
`
`mmollL
`
`mmollL
`
`mmollL
`
`mmollL
`
`mmol/t.
`
`Table 2 : Solubility and appearance of the solution after storage for up to 24 hrs at room
`temperature; conform release: no precipitate, no “flakes"
`
`m Solubility
`
`at 3hrs
`
`Appearance
`
`at 24 hrs
`
`M: within 1 min.
`+ : 5 mln.
`-
`: within 10 mln., but some material sticker! to the wall and did not dissolve completely due to the small volume.
`
`The stability of C1-inhibitor activity after reconstitution was determined at t0 h t=1 h. t=3 h t=6 h
`and t= 24 h (Table 2) and no loss of C1 -inhibitor activity was observed after storage at room
`temperature for up to 24 hrs (Table 3; Figure 1). For the 200 Ulml experiments the measured C1-
`inhibitor concentration was lower than calculated, but the C1-inhibitor activity did not change after
`storage. It was decided to repeat the experiment with the 100. 200 and 500 Ulml fonnulatlons and
`the results are presented in Table 4. For the 200 Ulml experiments the measured C1-inhibitor
`concentration was as expected and thus higher than in the first experiment . However, in this
`experiment the Clinhibitor concentration in the 500 Ulml formulation was lower than calculated.
`The osmolality and pH of the samples were determined (Table 5).
`Also, HPSEC analysis was performed showing that there was no aggregation or degradation after
`storage for up to 24 hrs, even for the highest concentration, 500 Ulml. tested (Figure 2 to 6).
`
`4
`
`Conclusions
`
`it can be concluded that dissolving the regular product in less w.f.i. to obtain a presentation
`containing up to 500 Ulml does not affect the stability of the product after reconstitution. However.
`due to the high concentration of the exclplents more experiments are needed to find a formulation
`containing a high concentration of C1-inhibitor at lower concentrations of excipients.
`
`Page 3 of 8
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`036 — 152
`
`4 - 8
`
`Table 3: C1-inhibitor activity after dissolution and storage for up to 24 hrs at room temperature
`
`Activity
`
`U/ml
`
`Yield
`(%)
`
`U/mlé
`
`Antlgen
`
`theoretical
`
`3 L
`
`Ratlo
`Actlvlutylentlgen
`
`.“ 0| ,3 G)
`
`1003deA
`romeo-sow
`44444§nllllllll
`
`Page 4 of 8
`
`44444llllIIIIIInoun-sob
`
`N 0!44444544444-IIIIIIII"allllllMow-Iownmw-xoA85
`
`{)2o
`
`2ml;
`
`T T T T T
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`036-152
`
`5-8
`
`Table 4: C1 -inhibilor activity after dissolution and storage for up to 24 hrs at room temperature;
`second experiment
`
`
`Activity
`
`U/ml
`
`Yield
`(%)
`
`Antigen
`
`theoretical
`
`. IL
`
`Ratio
`Activitylantigen
`U/m .
`
`Q 0
`
`IIIIII:3IIIIIIIINOD—KONQJO«h-8&-
`OIIIIIIII“III
`NOD—‘0
`
`T T T T
`
`. m
`
`T T T T
`
`.5 55
`
`4444
`
`.5
`1 ml,’ 500 U/ml
`
`Table 5: Osmolality and pH at t=0
`
`—-“mosmollk
`
`5 ml; 100 U/ml
`
`2.5 ml: 200 U/ml
`
`2 ml; 250 U/ml
`
`1.5 m1; 333 U/ml
`
`'pH ls determined with pH paper due to small volume left
`
`Page 5 of 8
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`6 - 8
`
`—e— '100 Ulml'
`
`4— '200 U/ml'
`
`+ '250 Ulml'
`
`-u-— '333 Ulml'
`
`+ '500 U/ml'
`
`Figure 1: Stability of Cimyze after dissolution at high concentrations.
`
`0.“
`
`
`0.00
`I.”
`1m
`“N
`am
`at.»
`Q.“
`I00
`4m
`45."
`“DO
`I.”
`”M KW m
`M
`
`Fleure 2: HPSEC analysis of Cirrryze alter dissolution in 5 ml and storage for up to 24 h at room
`temperature.
`Samples were taken after storage for 10 min, 1 h, 3 h. 6 h and 24 h.
`
`Page 6 of 8
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`036 - 152
`
`7 - 8
`
`010
`
`(IO
`
`“N
`
`00'
`
`fill
`
`am
`
`
`
`am
`
`eaoo
`MI.
`
`Figure 3: HPSEC analysis of Clnryze alter dissolution in 2.5 ml and storage for up to 24 h at room
`temperature.
`Samples were taken after storage for 10 min, 3 h, 6 h and 24 h. The highest peaks
`(black) are the t=0 sample where accidentally a double concentration was analysed.
`
`1M
`
`00”
`
`ROM
`
`M”
`
`0.“.
`
`”a
`
`0.".
`
`O”
`
`Q”
`
`I”
`
`n.
`
`It.
`
`am
`
`
`
`3.13
`
`..w—e—w—v—rc—u—u—v—ru—v—v—ufi
`I”
`I.“
`8‘ O
`O.”
`“I
`
`~
`
`45.“
`
`It”
`
`um
`
`I!“
`
`II.“
`
`M”
`
`Figure 4: HPSEC analysis of Clnryze alter dissolution in 2 ml and storage for up to 24 h at room
`temperature.
`Samples were taken alter storage for 10 mln. 1 h, 3 h. 6 h and 24 h.
`
`Page 7 of 8
`
`

`

`SANQUIN PLASMA PRODUCTS
`
`Research Report Department of Product Development
`
`0_____—_—_____—_36—152 - 8
`
`
`
`
`
`MN
`
`0 M
`
`9.”
`
`0,0,0
`
`0.”
`
`$.09
`0.000
`
`0.0”
`
`0.020
`
`0”
`
`500
`
`I0"
`
`
`
`-.—-v—r .—,—v—.—.—.—T—.—.—.——.—.—.—.—.—,—.———.— 1fiq-r—v—‘fifi—v—7T—v—rv—TH—H—v—(fi —.— -.—,—v—.— .
`ll“
`20“
`25.”
`30.00
`3500
`to.“
`1500
`NW
`”N
`”.00
`“00
`70.”
`Mules
`
`Figure 5: HPSEC analysis of Cinryze after dissolution in 1.5 ml and storage for up to 24 h at room
`temperature.
`Samples were taken after storage for 10 min, 1 h. 3 h, 6 h and 24 h.
`
`man
`
`
`
`0 on
`
`O 000
`
`0070
`
`0..“
`
`0010 .‘_, ..-,
`
`3m
`
`£030
`
`101.
`
`19.301
`
`Figure 6: HPSEC analysis of Cinryze after dissolution in 1 ml and storage for up to 24 h at room
`temperature.
`Samples were taken after storage for 10 min, 1 h, 3 h, 6 h and 24 h.
`
`Page 8 of 8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket